β-Lactamyl vasopressin V

1a Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on-1-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of disease states responsive to antagonism of the vasopressin Vreceptor.

Saved in:
Bibliographic Details
Main Authors Bruns, Jr, Robert F, Guillon, Christophe D. G, Heindel, Ned D, Koppel, Gary A, Miller, Marvin J
Format Patent
LanguageEnglish
Published 10.10.2006
Online AccessGet full text

Cover

More Information
Summary:1a Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on-1-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of disease states responsive to antagonism of the vasopressin Vreceptor.